SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827809-17-000052
Filing Date
2017-11-09
Accepted
2017-11-09 16:02:56
Documents
70
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nvln-093017x10q.htm 10-Q 853711
2 EXHIBIT 10.1 a20170930_exhibit101.htm EX-10.1 62892
3 EXHIBIT 10.2 a20170930_exhibit102.htm EX-10.2 12026
4 EXHIBIT 31.1 a20170930_exhibit311.htm EX-31.1 12383
5 EXHIBIT 31.2 a20170930_exhibit312.htm EX-31.2 12422
6 EXHIBIT 32.1 a20170930_exhibit321.htm EX-32.1 6036
7 EXHIBIT 32.2 a20170930_exhibit322.htm EX-32.2 6313
14 nvlnlogoa04.jpg GRAPHIC 76701
  Complete submission text file 0000827809-17-000052.txt   4366631

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aegr-20170930.xml EX-101.INS 738083
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aegr-20170930.xsd EX-101.SCH 39170
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aegr-20170930_cal.xml EX-101.CAL 72653
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aegr-20170930_def.xml EX-101.DEF 163827
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aegr-20170930_lab.xml EX-101.LAB 429128
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aegr-20170930_pre.xml EX-101.PRE 273826
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 171190692
SIC: 2834 Pharmaceutical Preparations